About the
NeLM
|
Help & Support
|
Site Feedback
|
Update Newsletter Subscription
Homepage
Login
|
Register
Search the NeLM
Medicines A-Z
Find key information about medicines by name (prototype)
Browse by Categories:
BNF Category
|
Medical Specialty
|
National Health Service
|
Medicines Information
Browse by NeLM area:
Evidence
|
Other Library Updates
|
News
|
Health In Focus
|
Medicines A-Z
|
Communities
|
Useful Links
|
Formularies
BNF Category
1: Gastro-intestinal system
2: Cardiovascular system
3: Respiratory system
4: Central nervous system
5: Infections
6: Endocrine system
7: Obstetrics, gynaecology, and urinary-tract disorders
8: Malignant disease and immunosuppression
9: Nutrition and blood
10: Musculoskeletal and joint diseases
11: Eye
12: Ear, nose, and oropharynx
13: Skin
14: Immunological products and vaccines
15: Anaesthesia
Appendix 7
Appendix 8 Wound management products and elasticated garments
Non-BNF miscellaneous
Emergency treatment of poisoning
5.1 Antibacterial drugs
5.2 Antifungal drugs
5.3 Antiviral drugs
5.4 Antiprotozoal drugs
5.5 Anthelmintics
5.3.1 HIV infection
5.3.2 Herpesvirus infections
5.3.3 Viral hepatitis
5.3.4 Influenza
5.3.5 Respiratory syncytial virus
1202 library items
in 5.3 Antiviral drugs
Filter results by:
Date Published
2012 (70)
2011 (207)
2010 (201)
2009 (281)
2008 (182)
More
NeLM
Area
News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies
Results filtered by:
Category
5: Infections (
remove
)
,
5.3 Antiviral drugs (
remove
)
Sort by:
Least recent publication date
Most recent publication date
Title alphabetical A-Z
Title alphabetical Z-A
Source alphabetical A-Z
Source alphabetical Z-A
Display summary:
No
Yes
Results 1 - 10 of 1202
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next
1.
ACH-3102 receives Fast Track Designation in the US for the treatment of chronic Hepatitis C
Source:
PharmaLive
,
Date published:
15/05/2012
Category:
5.3.3 Viral hepatitis
|
Hepatitis and other gastrointestinal infections
|
New drugs
NeLM
Area:
News
Link
2.
Horizon scanning: FDA panel supports approval of Quad for HIV despite concerns about adverse renal effects
Source:
The pharmaletter, Reuters
,
Date published:
14/05/2012
Category:
5.3.1 HIV infection
|
Adverse Drug Reactions
|
Food &Drug Administration (FDA)
|
HIV Infection/AIDS
|
New drugs
NeLM
Area:
News
Link
Link
3.
Horizon scanning: Truvada supported for prevention of HIV by FDA advisory panel
Source:
BBC news
,
Date published:
11/05/2012
Category:
5.3.1 HIV infection
|
Food &Drug Administration (FDA)
|
HIV Infection/AIDS
|
Licence extension
|
Preventative medicines
NeLM
Area:
News
BBC Story
4.
Barriers to medication adherence in HIV-infected children and youth based on self- and caregiver report
Source:
Pediatrics
,
Date published:
02/05/2012
Category:
5.3.1 HIV infection
|
Compliance
|
Paediatrics
NeLM
Area:
Evidence
>
Medicines Management
>
References
Abstract link
5.
Who forgot? The challenges of family responsibility for adherence in vulnerable pediatric populations
Source:
Pediatrics
,
Date published:
02/05/2012
Category:
5.3.1 HIV infection
|
Compliance
|
Paediatrics
NeLM
Area:
Evidence
>
Medicines Management
>
References
Extract link
6.
Review: Hepatitis E
Source:
Lancet
,
Date published:
30/04/2012
Category:
5.3.3 Viral hepatitis
|
Viral
NeLM
Area:
News
Abstract
7.
FDA Drug Safety Communication: Updated information on drug interactions between boceprevir (Victrelis®) and certain boosted HIV protease inhibitor drugs
Source:
FDA
,
Date published:
27/04/2012
Category:
5.3.1 HIV infection
|
5.3.3 Viral hepatitis
|
Drug Interactions
|
Food &Drug Administration (FDA)
|
Hepatitis and other gastrointestinal infections
|
HIV Infection/AIDS
NeLM
Area:
News
FDA press release
FDA MedWatch story
8.
The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review
Source:
Patient Preference and Adherence
,
Date published:
27/04/2012
Category:
5.3.1 HIV infection
|
HIV Infection/AIDS
|
Hospital pharmacy
NeLM
Area:
Evidence
>
Medicines Management
>
References
Full text link (PDF)
9.
Costing template for NICE guidance on boceprevir and telaprevir for genotype 1 chronic hepatitis C
Source:
NICE
,
Date published:
25/04/2012
Category:
5.3.3 Viral hepatitis
|
Clinical guidelines
|
Hepatitis and other gastrointestinal infections
|
National Institute of Clinical Excellence (NICE)
NeLM
Area:
News
Link to costing template
Link to boceprevir guidance (TA 253)
Link to telaprevir guidance (TA 252)
10.
NICE issues final guidance recommending boceprevir for the treatment of genotype 1 chronic hepatitis C
Source:
NICE
,
Date published:
25/04/2012
Category:
5.3.3 Viral hepatitis
|
Clinical guidelines
|
Hepatitis and other gastrointestinal infections
|
National Institute of Clinical Excellence (NICE)
NeLM
Area:
Evidence
>
Guidelines
Link to guidance (TA 253)
Link to telaprevir guidance (TA 252)
Results 1 - 10 of 1202
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next